Personal MedSystems beats its way to series B

Personal cardiac monitor developer Personal MedSystems has secured $5.4m in a round backed by Sino German High-Tech Fund, NRW Bank and KfW.

Germany-based cardiac health technology developer Personal MedSystems has received €5m ($5.4m) in series B funding from backers including Sino German High-Tech Fund, which is backed by the Chinese and German governments.

The round also featured development banks KfW and NRW Bank, the latter of which represents the German state North Rhine-Westphalia, VC fund High-Tech Gründerfonds and KPN Ventures, the corporate venturing arm of telecommunications company KPN.

Personal MedSystems has built a smartphone-based, personal electrocardiogram device called CardioSecur capable of providing instant feedback on heart symptoms through an app. Seventure Partners had previously invested €2.5m in the company in 2013.

Sino-German High-Tech Fund managing director Alex Liu said: “We are impressed by the innovative and professional services and products provided by Personal MedSystems.

"Its expertise in instant cardiac monitoring service and creative spirits have enabled it to deliver great value in [the mobile health] industry. We look forward to working with the experienced management team to help scale new heights and contribute to public health.”


See more from this Government Report: Germany, People's Republic of China


Copyright Mawsonia Limited 2010. Please don't cut articles from or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. Radiology Partners administers $200m round

    May 04, 2017

  2. Wuxi NextCode programs $75m series B

    May 03, 2017

  3. Temasek helps quicken Calysta with $40m

    May 02, 2017

  4. Riskmethods assesses $14.7m series B

    May 02, 2017

  5. Taranis harvests $7.5m series A

    May 05, 2017


  • 23 May - 24 May, 2017

    GCV Symposium 2017 - London

    Join 400+ business leaders from the corporate venturing and wider high growth business ecosystem for the two-day 2017 GCV Symposium.

  • More Events